Cardio Diagnostics Holdings, Inc. Finite-Lived Intangible Assets, Net
Cardio Diagnostics Holdings, Inc. (CDIO) had Finite-Lived Intangible Assets, Net of $1.33 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-03-13
- 2025-03-31: Finite-Lived Intangible Assets, Net $1.33K.
- 2024-12-31: Finite-Lived Intangible Assets, Net $5.33K.
- 2024-09-30: Finite-Lived Intangible Assets, Net $9.33K.
- 2024-06-30: Finite-Lived Intangible Assets, Net $13.33K.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2025-03-31 | $1.33K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $5.33K 10-K · filed 2026-03-13 |
| 2024-09-30 | $9.33K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $13.33K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $17.33K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $21.33K 10-K · filed 2025-03-20 |
| 2023-09-30 | $25.33K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $29.33K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $33.33K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $37.33K 10-K · filed 2024-04-01 |
| 2021-12-31 | $53.33K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |